| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $18.38B | $19.85B | $21.66B | $18.45B | $14.78B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | $11.88B |
| R&D | $43.00M | $32.00M | $23.00M | $11.00M | $17.00M |
| SG&A | – | – | – | – | – |
| Operating Income | $4.93B | $4.47B | $4.88B | $4.37B | $2.90B |
| Interest Expense | $1.81B | $1.71B | $1.60B | $1.07B | $928.00M |
| Tax Expense | $821.00M | $831.00M | $876.00M | $1.26B | $442.00M |
| Net Income | $2.90B | $2.29B | $7.80B | $2.35B | $1.64B |
| EPS (basic) | 0.6160 | 0.6200 | 2.1310 | 0.6540 | 0.4660 |
| EPS (diluted) | 0.6140 | 0.6170 | 2.1210 | 0.6500 | 0.4630 |
| Shares (diluted) | $4.73B | $3.71B | $3.68B | $3.62B | $3.54B |